Clinical Study
Aminoterminal Pro B-Type Natriuretic Peptide (NT-proBNP) Levels for Monitoring Interventions in Paediatric Cardiac Patients with Stenotic Lesions
Table 3
Change of NT-proBNP concentrations (pg/mL) before and after intervention.
| | Hemodynamic status | Number of patients | NT-proBNP (pg/mL) (median and range) | Peak gradient (mm Hg) (median and range) | | Before | After | P | Before | After | P |
| | Unchanged | 6 | 209 (10–460) | 202 (20–338) | ns | 40 (10–100) | 33 (10–90) | ns | | Improvement | 35 | 409 (20–263.000) | 145 (20–10.300) | <.0001 | 64 (20–125) | 10 (0–90) | <.0001 |
|
|
Unchanged indicates patients with dP <15 mmHg after procedure.
|
